Physician profile
Helen Anne Merritt
NPI 1790075927
$4,206.88
in general payments reported to CMS, 2019-2025
17 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $195 · 2021: $384 · 2022: $416 · 2023: $718 · 2024: $1,562 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,012 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,011.85 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,055.66 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $852.13 | 2020-2023 | Tepezza |
| Merz Pharmaceuticals, LLC | $319.78 | 2021-2025 | Xeomin |
| Eyevance Pharmaceuticals LLC | $199.29 | 2019-2021 | |
| Edwards Lifesciences Corporation | $133.43 | 2022-2023 | Sapien 3 Ultra Resilia |
| Bausch & Lomb Americas INC. | $124.74 | 2023 | Ic-8 Apthera Iol, Envista Mx60 Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $88.24 | 2019 | |
| Atricure, INC. | $88.11 | 2022 | |
| Halozyme INC | $79.28 | 2021-2024 | Hylenex Recombinant |
| Tarsus Pharmaceuticals, INC. | $66.12 | 2025 | Xdemvy |
| Merz North America, INC. | $59.66 | 2019-2020 | |
| Shire North American Group INC | $46.57 | 2019 | |
| Biotissue Holdings INC. | $27.76 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Omeros Corporation | $18.58 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $15.38 | 2023 | Vascband |
| Conetic Solutions, INC. | $12.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Merritt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.